Presentation is loading. Please wait.

Presentation is loading. Please wait.

Volume 133, Issue 2, Pages (August 2007)

Similar presentations


Presentation on theme: "Volume 133, Issue 2, Pages (August 2007)"— Presentation transcript:

1 Volume 133, Issue 2, Pages 713-716 (August 2007)
Seek and Hide Phosphatidylserine: A New Approach to Prevent Hepatic Ischemia/Reperfusion Injury  Emanuele Albano  Gastroenterology  Volume 133, Issue 2, Pages (August 2007) DOI: /j.gastro Copyright © 2007 AGA Institute Terms and Conditions

2 Figure 1 Events responsible for the pathogenesis of hepatic ischemia/reperfusion injury and mechanisms of action of some pharmacologic agents that have been reported to confer protection against liver damage.8–10 Hypoxia causes the depletion of cellular ATP, mitochondrial de-energization, alterations of H+, Na+, and Ca2+ homeostasis and conversion of xanthine dehydrogenase (XDH) to xanthine oxidase (XOD). Upon re-oxygenation, the formation of ROS by uncoupled mitochondria and XOD promotes oxidative stress and mitochondrial permeability transition that leads to cell death by either necrosis or apoptosis. Concomitantly, the activation of Kupffer cells releases ROS, NO, eicosanoids and pro-inflammatory cytokines/chemokines (TNF-α, IL-6, IL-1β, MCP-1, IL-12, IL-8). These pro-inflammatory mediators, in concert with the increased expression of adhesion molecules (ICAM-1, VCAM-1 P- and E-selectins) by sinusoidal endothelial cells, promote liver infiltration by granulocytes and monocytes. CD4+ T lymphocytes can also contribute to hepatic reperfusion injury. Gastroenterology  , DOI: ( /j.gastro ) Copyright © 2007 AGA Institute Terms and Conditions


Download ppt "Volume 133, Issue 2, Pages (August 2007)"

Similar presentations


Ads by Google